- Home
- TLSI vs SKYX Comparison
TLSI vs SKYX Comparison
Compare TLSI & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- SKYX
- Stock Information
- Founded
- TLSI 2010
- SKYX 2004
- Country
- TLSI United States
- SKYX United States
- Employees
- TLSI N/A
- SKYX N/A
- Industry
- TLSI Medical Specialities
- SKYX Building Products
- Sector
- TLSI Health Care
- SKYX Consumer Discretionary
- Exchange
- TLSI Nasdaq
- SKYX Nasdaq
- Market Cap
- TLSI 150.0M
- SKYX 127.2M
- IPO Year
- TLSI N/A
- SKYX 2022
- Fundamental
- Price
- TLSI $4.55
- SKYX $1.11
- Analyst Decision
- TLSI Strong Buy
- SKYX Strong Buy
- Analyst Count
- TLSI 5
- SKYX 2
- Target Price
- TLSI $10.90
- SKYX $3.50
- AVG Volume (30 Days)
- TLSI 82.1K
- SKYX 456.2K
- Earning Date
- TLSI 08-12-2025
- SKYX 08-12-2025
- Dividend Yield
- TLSI N/A
- SKYX N/A
- EPS Growth
- TLSI N/A
- SKYX N/A
- EPS
- TLSI N/A
- SKYX N/A
- Revenue
- TLSI $35,990,000.00
- SKYX $89,028,500.00
- Revenue This Year
- TLSI $55.39
- SKYX $18.78
- Revenue Next Year
- TLSI $54.89
- SKYX $29.23
- P/E Ratio
- TLSI N/A
- SKYX N/A
- Revenue Growth
- TLSI 45.50
- SKYX 5.71
- 52 Week Low
- TLSI $3.42
- SKYX $0.80
- 52 Week High
- TLSI $6.03
- SKYX $2.14
- Technical
- Relative Strength Index (RSI)
- TLSI 54.40
- SKYX 49.81
- Support Level
- TLSI $3.42
- SKYX $1.07
- Resistance Level
- TLSI $4.30
- SKYX $1.28
- Average True Range (ATR)
- TLSI 0.41
- SKYX 0.09
- MACD
- TLSI 0.04
- SKYX 0.02
- Stochastic Oscillator
- TLSI 80.14
- SKYX 46.88
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About SKYX SKYX Platforms Corp.
SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.